Salivary gland tumors: A 13-year clinicopathologic retrospective study in a Brazilian northeast population
- PMID: 36911148
- PMCID: PMC9994649
- DOI: 10.4317/jced.59738
Salivary gland tumors: A 13-year clinicopathologic retrospective study in a Brazilian northeast population
Abstract
Background: The present study aimed to evaluate the clinicopathologic features of salivary gland tumors (SGTs) in a Brazillian northeast population.
Material and methods: A retrospective descriptive cross-sectional study was performed (1995-2009). All cases of SGTs diagnosed in a private surgical pathology service in Brazil were reviewed, and clinicopathological data were collected.
Results: A total of 23.258 histopathological records of biopsies were analyzed, and 174 cases were diagnosed as SGTs (0.7%). Of these, 117 (67.2%) were classified as benign, and 57 (32.8%) were malignant. The series comprised 89 females (51.1%) and 85 males (48.9%), with a mean age of 50.2 years (range: 3-96 years) and a roughly equal female-to-male ratio (1:1). Most tumors occurred in the parotid gland (n = 82, 47.1%), followed by the palate (n = 45, 25.9%), submandibular gland (n = 15, 8.6%). Pleomorphic adenoma (n = 83; 70.9%) and mucoepidermoid carcinoma (n = 19, 33.3%) were the most frequent benign and malignant tumors, respectively. After reevaluation of morphology and immunohistochemical analysis, seven tumors (4.0%) were reclassified following the current WHO Classification of the Head and Neck Tumors.
Conclusions: The general features of SGT from the studied Brazilian population were similar to previously published reports in other countries. However, SGTs do not show any sex predilection. Although careful morphological analysis is the key to the correct diagnosis of these tumors, immunohistochemical analysis is essential to establish an accurate diagnosis in the face of challenging cases. Key words:Salivary gland tumors, epidemiology, head and neck pathology.
Copyright: © 2023 Medicina Oral S.L.
Conflict of interest statement
Conflicts of interest No conflicts of interest were declared concerning the publication of this article.
Figures
Similar articles
-
Epidemiologic analysis of salivary gland tumors over a 10-years period diagnosed in a northeast Brazilian population.Med Oral Patol Oral Cir Bucal. 2020 Jul 1;25(4):e516-e522. doi: 10.4317/medoral.23532. Med Oral Patol Oral Cir Bucal. 2020. PMID: 32388524 Free PMC article.
-
Salivary Gland Tumors: A Clinicopathologic Analysis From Taipei Veterans General Hospital.Ann Plast Surg. 2020 Jan;84(1S Suppl 1):S26-S33. doi: 10.1097/SAP.0000000000002178. Ann Plast Surg. 2020. PMID: 31833885
-
Epidemiological, Clinical, and Histopathological Features of Salivary Gland Tumors among 150 Sudanese Patients: 10 Years' Experience.J Microsc Ultrastruct. 2022 Nov 9;11(2):92-96. doi: 10.4103/jmau.jmau_113_20. eCollection 2023 Apr-Jun. J Microsc Ultrastruct. 2022. PMID: 37448823 Free PMC article.
-
Salivary Gland Tumors: A Retrospective Study of 164 Cases from a Single Private Practice Service in Mexico and Literature Review.Head Neck Pathol. 2021 Jun;15(2):523-531. doi: 10.1007/s12105-020-01231-2. Epub 2020 Oct 12. Head Neck Pathol. 2021. PMID: 33044721 Free PMC article. Review.
-
Salivary gland tumours: an epidemiological review of non-neoplastic and neoplastic pathology.Br J Oral Maxillofac Surg. 2023 Jan;61(1):12-18. doi: 10.1016/j.bjoms.2022.11.281. Epub 2022 Dec 9. Br J Oral Maxillofac Surg. 2023. PMID: 36623970 Review.
References
-
- Silva LP, Serpa MS, Viveiros SK, Sena DAC, Pinho RFC, Guimarães LDA. Salivary gland tumors in a Brazilian population: A 20-year retrospective and multicentric study of 2292 cases. J Craniomaxillofac Surg. 2018;46:2227–2233. - PubMed
-
- Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population. Int J Oral Maxillofac Surg. 2010;39:235–42. - PubMed
LinkOut - more resources
Full Text Sources